Hong Kong in talks with mainland Chinese firm over Covid-19 treatment

Feb 22, 2022 | INVESTING

A mainland Chinese biotechnology firm has confirmed that it is in talks with the Hong Kong authorities about supplying the city with its Covid-19 treatment.Brii Biosciences said in a statement that detailed information could not be disclosed because of “the confidential nature of the conversation”.On Monday, the leading respiratory expert Zhong Nanshan recommended the treatment, a cocktail of drugs known as BRII 196-198, in a video message to Hong Kong, which is currently battling a surge in…

Read More

Pin It on Pinterest